Sign in
4

Changes in Ownership

Niagen Bioscience, Inc. Filed Acc 0001628280-23-029599

Chief Financial Officer acquired 22,436 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Gerber Brianna · Chief Financial Officer

Table I: Non-derivative

1 line
Date Transaction Shares Owned after D/I
2023-08-12 Exercise or conversion : show line 1 in the form +22,436 22,436 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2023-08-12 Exercise or conversion : show line 2 in the form Restricted Stock Unit −22,436 44,872 D
Loading xslF345X05/wk-form4_1692148297.xml…